Abstract
In cell therapy, the use of autologous and allogenic human mesenchymal stem cells is rising. Accordingly, the supply of cells for clinical applications in highest quality is required. As hMSCs are considered as an advanced therapy medicinal products (ATMP), they underlie the requirements of GMP and PAT according to the authorities (FDA and EMA). The production process of these cells must therefore be documented according to GMP, which is usually performed via a GMP protocol based on standard operating procedures. This chapter provides an example of such a GMP protocol for hMSC, here a genetically modified allogenic cell line, based on a production process in a microcarrier-based stirred tank reactor including process monitoring according to PAT and final product quality assurance.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hambor JE (2012) Bioreactor design and bioprocess controls for industrialited cell processing. BioProcess Int 10(6):22–33
Keating A (2012) Mesenchymal stromal cells: new directions. Cell Stem Cell 10:709–717
Salzig D, Ehlicke F, Dorresteijn A, Czermak P (2011) Potential of mesenchymal stem cells for regeneration of intervertebral disc. Biomaterialien 12(1–4):198
Oppermann T, Leber J, Elseberg C, Salzig D, Czermak P (2014) hMSC production in disposable bioreactors in compliance with cGMP guidelines and PAT. Am Pharmaceut Rev Bioprocess 4
Jung S, Panchalingam KM, Wuerth RD, Rosenberg L, Nehie LA (2012) Large-scale production of human mesenchymal stem cells for clinical applications. Biotechnol Appl Biochem 59(2):106–120
Chen AK, Reuveny S, Oh SK (2013) Application of human mesenchymal and pluripotent stem cell microcarrier cultures in cellular therapy: achievements and future direction. Biotechnol Adv 31(7):1032–1046
Reicin C, McMahon E, Chung C (2012) Stem cell therapy regulation in Canada: implications of the prochymal approval. Westlaw J 28:1–4
Wang S, Qu X, Zhao R (2012) Clinical applications of mesenchymal stem cells. J Hematol Oncol 5:1–9
English K, French A, Wood K (2010) Mesenchymal stromal cells: facilitators of successful transplantation? Cell Stem Cell 7:431–442
Lindgren CG (2009) Standard operating procedures. In: Gee A (ed) Cell therapy: cGMP facilities and manufacturing. Springer, New York, NY
Unger C, Skottman H, Blomberg P, Dilber M, Hovatta O (2008) Good manufacturing practice and clinical-grade human embryonic stem cell lines. Hum Mol Genet 17(1):48–53
Salzig D, Schmiermund A, Pino-Grace P, Elseberg C, Weber C, Czermak P (2013) Enzymatic detachment of therapeutic mesenchymal stromal cells grown on glass carriers in a bioreactor. Open Biomed Eng J 7:147–158
Cierpka K, Elseberg C, Niss K, Kassem M, Salzig D, Czermak P (2013) hMSC production in disposable bioreactors with regards to GMP and PAT. Chem Ing Tech 85(1–2):67–75
Weber C, Pohl S, Freimark D, Poertner R, Pino-Grace P, Wallrapp C, Geigle P, Czermak P (2010) Expansion of human mesenchymal stem cells in a fixed-bed bioreactor system based on non-porous glass carrier: part A—inoculation, cultivation, and cell harvest procedures. Int J Artif Org 33(8):512–525
Weber C, Pohl S, Poertner R, Pino-Grace P, Wallrapp C, Geigle P, Czermak P (2010) Expansion of human mesenchymal stem cells in a fixed-bed bioreactor system based on non-porous glass carrier: part B—modeling and scale up. Int J Artif Org 33(11):782–795
Weber C, Pohl S, Poertner R, Pino-Grace P, Freimark D, Wallrapp C, Geigle P, Czermak P (2010) Production process for stem cell based therapeutic implants: expansion of the production cell line and cultivation of encapsulated cells. Adv Biochem Eng Biotechnol 123:143–162
Weber C, Pohl S, Poertner R, Wallrapp C, Geigle P, Czermak P (2009) Fixed bed reactor systems for the expansion and differentiation of stem cells for cell therapy. Int J Artif Organs 32(7):418
Czermak P, Weber C, Pohl S, Poertner R, Wallrapp C, Geigle P (2008) Development of a production process for stem cell based cell therapeutic implants. Int J Artif Organs 31(7):584
Czermak P, Weber C, Salzig D, Pörtner R, Wallrapp C, Hudel K (2011) Stammzellbasierte zelltherapeutische Implantate: Entwicklung eines Herstellungs- und Kryokonservierungsverfahrens. Biomaterialien 12(1–4):187
Freimark D, Sehl C, Grein T, Weber C, Hudel K, Glasmacher B, Czermak P (2010) Stem cell based therapeutic implants: production and storage. Int J Artif Organs 33(7):426
Justice C, Leber J, Salzig D, Wallrapp C, Kassem M, Kraume M, Czermak P (2012) Microcarrier based expansion process of hMSCs in highly vital and non-differentiated quality. Int J Artif Organs 35(2):39–107
Druzinec D, Weiss K, Elseberg C, Salzig D, Kraume M, Poertner R, Czermak P (2014) Process analytical technology (PAT) in insect and mammalian cell culture processes: dielectric spectroscopy and focused beam reflectance measurement (FBRM). Methods Mol Biol 1104:313–341
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4):315–317
Justice C, Leber J, Freimark D, Pino-Grace P, Kraume M, Czermak P (2011) Online- and offline-monitoring of stem cell expansion on microcarrier. Cytotechnol 63(4):325–335. doi:10.1007/s10616-011-9359-4
Justice C, Brix A, Freimark D, Kraume M, Pfromm P, Eichenmueller B, Czermak P (2011) Process control in cell culture technology using dielectric spectroscopy. Biotechnol Adv 29(4):391–401
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Elseberg, C.L., Salzig, D., Czermak, P. (2014). Bioreactor Expansion of Human Mesenchymal Stem Cells According to GMP Requirements. In: Turksen, K. (eds) Stem Cells and Good Manufacturing Practices. Methods in Molecular Biology, vol 1283. Humana Press, New York, NY. https://doi.org/10.1007/7651_2014_117
Download citation
DOI: https://doi.org/10.1007/7651_2014_117
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2434-9
Online ISBN: 978-1-4939-2435-6
eBook Packages: Springer Protocols